£515.00

It has never been this cheap. We have no record of a lower price.

£515 today · cheaper than every other day in the last 3 months

Non-Hodgkin's and Chronic Lymphoma Market Outlook in India

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 89 days · 89 data points

Historical
Generating forecast…
£515.00 £489.25 £499.55 £509.85 £520.15 £530.45 £540.75 12 August 2026 03 September 2026 25 September 2026 17 October 2026 08 November 2026
View at Amazon ↗

Price data checked 2 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 89 days • 1 price levels

Days at Price
89 days 0 22 45 67 89 £515 Days at Price

Price Analysis

Most common price: £515 (89 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 89 days

Description

This comprehensive market study provides a detailed outlook for non-Hodgkin's lymphoma and chronic lymphoma treatments in India from 2023 to 2028. The report focuses on latent demand, offering potential industry earnings (P.I.E.) estimates in millions of U.S. dollars. Data is analyzed across states, union territories, and over 4,900 cities to provide a granular view of the market landscape. By providing the percent share of each city relative to its state, union territory, and the country as a whole, this study offers comparative benchmarks for industry professionals. These statistics serve as a practical tool for distribution teams and sales forces looking to optimize their operations and target specific regions within the Indian market.

Key Features

Provides latent demand estimates in millions of U.S. dollars for non-Hodgkin's and chronic lymphoma treatments in India.

Covers market outlook data for the period spanning 2023 to 2028.

Includes detailed analysis across more than 4,900 cities, states, and union territories throughout India.

Offers comparative benchmarks by reporting the percent share of each city relative to its state and the national market.

Supports sales force and distribution planning through detailed potential industry earnings (P.I.E.) estimates.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
28 September 2022

Similar Products You Might Like

Non-Hodgkin Lymphoma Treatment Outlook 2023-2028 Report
99% match

Non-Hodgkin Lymphoma Treatment Outlook 2023-2028 Report

£520.00 13 Sep 2026
World Outlook 2025-2030: Non-Hodgkin's & Chronic Lymphoma
99% match

World Outlook 2025-2030: Non-Hodgkin's & Chronic Lymphoma

£790.00 07 Nov 2026
The 2023-2028 Outlook for Lymphoma Treatments in the United States
99% match

The 2023-2028 Outlook for Lymphoma Treatments in the United States

£520.00 26 Aug 2026
Lymphoma Treatment Outlook in India 2023-2028 Study
99% match

Lymphoma Treatment Outlook in India 2023-2028 Study

£515.00 06 Nov 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China
99% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China

£495.00 07 Nov 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in Japan
99% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in Japan

£495.00 06 Nov 2026
World Outlook for Non-Hodgkin Lymphoma Treatments 2025-2030
99% match

World Outlook for Non-Hodgkin Lymphoma Treatments 2025-2030

£790.00 06 Nov 2026
Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028
99% match

Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028

£515.00 07 Nov 2026
Non-Hodgkin Lymphoma Chemotherapy Outlook 2023-2028 Study
99% match

Non-Hodgkin Lymphoma Chemotherapy Outlook 2023-2028 Study

£520.00 07 Nov 2026
Non-Hodgkin and Chronic Lymphoma Treatment Outlook 2023-2028
99% match

Non-Hodgkin and Chronic Lymphoma Treatment Outlook 2023-2028

£490.00 28 Aug 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan
98% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan

£495.00 07 Nov 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China
98% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China

£495.00 02 Oct 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan
98% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan

£495.00 25 Aug 2026
The 2023-2028 Outlook for Lymphoma Treatments in China
98% match

The 2023-2028 Outlook for Lymphoma Treatments in China

£495.00 06 Nov 2026
Non-Hodgkin Lymphoma Treatment Outlook 2023-2028 Study
98% match

Non-Hodgkin Lymphoma Treatment Outlook 2023-2028 Study

£490.00 25 Aug 2026
Lymphoma Therapeutics in Africa: 2013-2018 Outlook Study
98% match

Lymphoma Therapeutics in Africa: 2013-2018 Outlook Study

£325.00 03 Sep 2026
Non-Hodgkin Lymphoma US Zip Code Outlook 2023-2028
98% match

Non-Hodgkin Lymphoma US Zip Code Outlook 2023-2028

£490.00 28 Aug 2026
The 2023-2028 Outlook for Lymphoma Treatments for US Zip Codes
98% match

The 2023-2028 Outlook for Lymphoma Treatments for US Zip Codes

£490.00 28 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India

£515.00 01 Oct 2026
Hematology and Oncology Products in India Outlook 2016-2021
97% match

Hematology and Oncology Products in India Outlook 2016-2021

£595.00 07 Nov 2026
US Hematology and Oncology Products Market Outlook 2016-2021
97% match

US Hematology and Oncology Products Market Outlook 2016-2021

£595.00 18 Sep 2026